Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report)’s stock price shot up 1.4% during trading on Monday . The company traded as high as €19.90 ($20.95) and last traded at €19.80 ($20.84). 4,478,001 shares changed hands during trading, The stock had previously closed at €19.52 ($20.55).
Bayer Aktiengesellschaft Trading Up 0.6 %
The company has a market cap of $19.58 billion, a price-to-earnings ratio of -15.35, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The business’s fifty day moving average price is €25.80 and its 200 day moving average price is €26.78. The company has a debt-to-equity ratio of 129.94, a current ratio of 1.27 and a quick ratio of 0.72.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Articles
- Five stocks we like better than Bayer Aktiengesellschaft
- The Risks of Owning Bonds
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What is the S&P 500 and How It is Distinct from Other Indexes
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Roth IRA Calculator: Calculate Your Potential Returns
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
